GLP-1 Analogues Market Key Takeaways In terms of revenue, the global GLP-1 analogues market was valued at USD 66.48 billion in 2025
Antroduodenal manometry reveals a decreased antral motility index in gastroparesis
These trials, which collectively involved more than 100,000 participants, provide compelling rationale for expedient and widespread vaccination of the global population
PMHNPs: State-Dependent, Often Requires Physician Collaboration Psychiatric Nurse Practitioners face a more complex landscape: Full Practice Authority (FPA) States (~24 states + D.C.): PMHNPs can prescribe weight-loss medications independently if they meet state criteria
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), along with glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) dual or triple receptor agonists that modulate multiple metabolic pathways, have attracted significant scientific interest due to their multifaceted roles in metabolic regulation
Oxidative stress in industrial fungi
